- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02075333
The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose
May 11, 2016 updated by: Prof Louise Dye, University of Leeds
The Effects of Ingesting or Rinsing Sucrose and Sucralose Solutions on Self-control, Cognitive Performance, and Blood Glucose Level
The purpose of this study is to examine the effects of ingesting or mouth rinsing a sucrose (carbohydrate) versus a sucralose (carbohydrate-free) drink on self control, cognitive performance, and blood glucose level.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leeds, United Kingdom, LS29JT
- Human Appetite Research Unit (University of Leeds)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 18 - 29 kg/m2
Exclusion Criteria:
- Dementia
- Depression
- Type 2 diabetes
- Phenylketonuria
- Intake of medication known to affect glucose metabolism
- Fasting blood glucose > 7.8 mmol/L
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Sucrose (50g)
A 381g blackcurrant drink (cordial and water) providing 50g of sucrose
|
Participants will ingest the solution
Participants rinse the solution in the oral cavity
|
|
PLACEBO_COMPARATOR: Sucralose (0.92 g sugars)
A 381g blackcurrant drink (cordial and water) providing 0.92g of natural sugars
|
Participants will ingest the solution
Participants rinse the solution in the oral cavity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Capillary blood glucose change from baseline following rinsing or ingesting sucrose or sucralose solutions
Time Frame: - 30, -15, - 5, + 5, + 10, + 20, + 30, + 40 minutes relative to rinsing or ingestion of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
Change from baseline in capillary blood glucose (assessed by lancet fingerprick and YSI blood glucose analyser)
|
- 30, -15, - 5, + 5, + 10, + 20, + 30, + 40 minutes relative to rinsing or ingestion of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual verbal learning and memory performance following self-control depletion
Time Frame: + 35 minutes post ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
Visual verbal learning performance will be assessed by the Visual Verbal Learning Test (Rey, 1964) following a self-control depletion task and ingestion or rinsing of a sucrose or sucralose solution
|
+ 35 minutes post ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
|
Attention switching performance following self-control depletion
Time Frame: + 20 minutes post ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
Attention switching performance will be assessed by a switch task (Rogers and Monsell, 1995) following a self-control depletion task and ingestion or rinsing of a sucrose or sucralose solution
|
+ 20 minutes post ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in crossover manner)
|
|
Continuous blood glucose change from baseline following rinsing or ingesting sucrose or sucralose solutions
Time Frame: 24 hours preceding and during ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in a crossover manner)
|
A subgroup of 10 participants recruited into the study will be fitted with a continuous glucose monitoring device (CGMS, iPRO) the day preceding each of the test days to measure continuous interstitial blood glucose levels
|
24 hours preceding and during ingestion or rinsing of sucrose or sucralose solutions (each separated by 7 days in a crossover manner)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Neil B Boyle, University of Leeds
- Study Chair: Louise Dye, University of Leeds
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (ACTUAL)
August 1, 2014
Study Completion (ACTUAL)
August 1, 2014
Study Registration Dates
First Submitted
February 26, 2014
First Submitted That Met QC Criteria
February 28, 2014
First Posted (ESTIMATE)
March 3, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
May 12, 2016
Last Update Submitted That Met QC Criteria
May 11, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SN - 0114
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Performance
-
Texas Tech University Health Sciences CenterTexas Tech UniversityNot yet recruitingStress | Performance | Cognitive Performance | Cognitive AbilitiesUnited States
-
Ankara UniversityBurdur Mehmet Akif Ersoy UniversityCompletedAnaerobic Performance Neuromuscular Performance Cognitive PerformanceTurkey (Türkiye)
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
Krzysztof MizeraCompletedCognitive Performance | Physical PerformancePoland
-
University of MoliseGiuseppe Calcagno; Giovanni Fiorilli; Andrea Buonsenso; Alessandra di CagnoCompletedAcademic Acheivement | Cognitive Performance | Physical PerformanceItaly
-
Qassim UniversityCairo UniversityEnrolling by invitationCognitive Performance | Cognitive Performance During Physical Activity | Sustained AttentionSaudi Arabia
-
Inonu UniversityPrincess Nourah bint Abdulrahman University, Riyadh, Saudi ArabiaCompletedHealthy Volunteers | Cognitive Performance | Anaerobic PerformanceTurkey (Türkiye)
-
PepsiCo Global R&DCompletedSleep | Cognitive Performance | Balance | Physical PerformanceAustralia
-
Sinop UniversityCompletedAthletic Performance | Cognitive Performance | Healthy Adult FemalesTurkey (Türkiye)
-
The Geneva Foundation59th Medical Wing; Uniformed Services University of the Health SciencesRecruitingCognitive PerformanceUnited States
Clinical Trials on Ingestion of solution
-
University of LausanneCompletedNormal SubjectsSwitzerland
-
University of ExeterQuornCompletedMuscle Protein SynthesisUnited Kingdom
-
National Institute of Cardiology, Laranjeiras,...CompletedEndothelial FunctionBrazil
-
Campus docent Sant Joan de Déu-Universitat de BarcelonaCompletedPulmonary Function | Nutrition, HealthySpain
-
University of CalgaryCanadian Diabetes Association; Becton, Dickinson and Company; LifeScan CanadaCompletedHypoglycemia | Type 1 Diabetes MellitusCanada
-
Inhale, IncCompleted
-
University of AarhusInnovation Fund Denmark; Arla Foods; Team DenmarkCompletedProtein Metabolism
-
University of LausanneUniversity of Lausanne HospitalsCompletedNormal SubjectsSwitzerland
-
University of ExeterQuornCompletedPostprandial Plasma Amino Acid AvailabilityUnited Kingdom